Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Shexiang Baoxin Pill treats acute myocardial infarction by promoting angiogenesis via GDF15-TRPV4 signaling
Bingyan Wei, Jianan Hou, Changping Yan, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115186-115186
Open Access | Times Cited: 10

Showing 10 citing articles:

Integrated metabolomics and network pharmacology to reveal the mechanisms of Shexiang Baoxin pill against atherosclerosis
Daisong Li, Ruolan Chen, Xiaojian Xu, et al.
Phytomedicine (2024) Vol. 135, pp. 156138-156138
Open Access | Times Cited: 6
Mechanisms of Postischemic Stroke Angiogenesis: A Multifaceted Approach
Bin Hu, Jingchun Pei, Cheng Wan, et al.
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 4625-4646
Open Access | Times Cited: 4
GDF15 attenuates sepsis-induced myocardial dysfunction by inhibiting cardiomyocytes ferroptosis via the SOCS1/GPX4 signaling pathway
Xiayun Li, He Sun, Liyun Zhang, et al.
European Journal of Pharmacology (2024) Vol. 982, pp. 176894-176894
Closed Access | Times Cited: 4
Growth and differentiation factor 15: An emerging therapeutic target for brain diseases
Yingying Zhou, Lei Dou, Luyao Wang, et al.
BioScience Trends (2025) Vol. 19, Iss. 1, pp. 72-86
Open Access
Efficacy and safety of Shexiang Baoxin Pill in patients with angina and non-obstructive coronary arteries: a multicenter, randomized, double-blind, placebo-controlled, phase Ⅳ clinical trial
Zhiqing He, N Li, Wei Zhang, et al.
Phytomedicine (2025) Vol. 139, pp. 156556-156556
Closed Access
Glycometabolic Regulation of Angiogenesis: Mechanisms and Therapeutic Strategies
Zhifeng Yao, Junting Li, Jiaming Yu, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2386-2386
Open Access
The potential role of miR-450a-1-3p in chromium-associated heart rate variability reduction
Bingdong Chen, Jiahao Song, Jiake Zhang, et al.
Environmental Pollution (2025), pp. 126117-126117
Closed Access
Verbascoside attenuates myocardial ischemia/reperfusion-induced ferroptosis following heterotopic heart transplantation via modulating GDF15/GPX4/SLC7A11 pathway
Yuxi Zhang, Jing Zhan, Zhen Qiu, et al.
(2025)
Closed Access
Shexiang Baoxin Pill alleviates atherosclerosis by inhibiting macrophage-mediated inflammation via suppressing KMT5A mediated Irf7 transcription
Shuo Cheng, Wei Luo, Zhonghua Zhang, et al.
Journal of Ethnopharmacology (2025), pp. 119833-119833
Closed Access
Mitigation of myocardial ischemia/reperfusion–induced chronic heart failure via Shexiang Baoxin Pill–mediated regulation of the S1PR1 signaling pathway
Xuan Xu, Shengnan Li, Tao Wang, et al.
Phytomedicine (2024) Vol. 128, pp. 155390-155390
Closed Access | Times Cited: 2
Page 1

Scroll to top